key: cord-0835837-rg18qq4a
authors: Jerez, Joaquín; Ernst, Daniel M.
title: High percentage of smudge cells in a patient with COVID19: Rediscovering their utility
date: 2020-07-03
journal: EJHaem
DOI: 10.1002/jha2.52
sha: 99048d7f6c7c2031e1e7d503a5d04ff760283e84
doc_id: 835837
cord_uid: rg18qq4a

We present a patient with SARS‐CoV‐2 infection, with an unexpected presence of lymphocytosis. Examination of blood film revealed mature small lymphocytes associated with high percentage of smudge cells (63%). A peripheral flow cyometry evidenced a CD5 negative CLL. A high percentage of smudge cells is associated with CLL diagnosis and has an important prognostic value: better survival and prolonged time to first treatment. It is a useful index in developing countries with low access to molecular testing.

treatment. It is a useful index in developing countries with low access to molecular testing.

biological aspects, blood morphology, chronic lymphocytic leukemia A 55-year-old man with a previous history of hypertension presented with myalgia, fever, dyspnea, and mild hypoxemia. A chest X-ray evi- for CD20 (dim) , CD23 (high) , CD200 (high) , and CD43 (dim) , and was negative for CD5, CD79b, and cell-surface light chain expression. A diagnosis of CD5-negative early-stage CLL was made. Total immunoglobulins were in normal range and after 7 days of hospital care, the patient continued to recover.

Smudge cells in peripheral blood smears did not differentiate chronic lymphocytic leukemia from other B-cell chronic lymphoprolipherative diseases

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia

Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: A universally available prognostic test

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

High percentage of smudge cells in a patient with COVID19: rediscovering their utility. eJHaem. 2020;1-2